SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-240492
Filing Date
2021-08-09
Accepted
2021-08-09 16:25:34
Documents
48
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d173852d10q.htm   iXBRL 10-Q 583632
2 EX-31.1 d173852dex311.htm EX-31.1 11367
3 EX-31.2 d173852dex312.htm EX-31.2 11373
4 EX-32.1 d173852dex321.htm EX-32.1 4044
5 EX-32.2 d173852dex322.htm EX-32.2 3979
  Complete submission text file 0001193125-21-240492.txt   3303930

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA flac-20210630.xsd EX-101.SCH 34122
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flac-20210630_cal.xml EX-101.CAL 15463
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flac-20210630_def.xml EX-101.DEF 172843
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flac-20210630_lab.xml EX-101.LAB 227073
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flac-20210630_pre.xml EX-101.PRE 213635
11 EXTRACTED XBRL INSTANCE DOCUMENT d173852d10q_htm.xml XML 451172
Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Filer) CIK: 0001828326 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39765 | Film No.: 211156849
SIC: 6770 Blank Checks